allulose benefits glp 1 Allulose, Type diabetes, & Therapeutic Carbohydrate Reduction GLP-1: Genetic Variants Related to
Description
Since 2005, glucagon-like peptide-1 receptor agonists (GLP-1RAs) have been used as key therapeutic agents for T2DM [4, 5, 6]
Additionally, exciting pipeline developments such as oral semaglutide and dual and triple agonists like retatrutide suggest continued growth in this therapeutic area
This captures abdominal fat loss better than total body weight
Addressing both hormonal and thyroid issues simultaneously is essential for effective management
